Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19

NCT04565249 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
6
Enrollment
INDUSTRY
Sponsor class

Stopped Study halted and will not resume; participants are no longer being examined or receiving intervention

Conditions

Interventions

Sponsor

Pliant Therapeutics, Inc.